Effective prevention and therapy of experimental allergic asthma using a GATA-3–specific DNAzyme
- 1 April 2008
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 121 (4), 910-916.e5
- https://doi.org/10.1016/j.jaci.2007.12.1175
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- How much is there really? Why stereology is essential in lung morphometryJournal of Applied Physiology, 2007
- GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factorsCell Research, 2006
- Involvement of distal airways in a chronic model of experimental asthmaClinical and Experimental Allergy, 2005
- Asthma: Mechanisms of Disease Persistence and ProgressionAnnual Review of Immunology, 2004
- Respirable antisense oligonucleotides: a new, third drug class targeting respiratory diseaseCurrent Opinion in Allergy and Clinical Immunology, 2002
- Bacterial DNA causes septic shockNature, 1997
- DNA antisense therapy for asthma in an animal modelNature, 1997
- Transcription factor GATA-3 is required for development of the T-cell lineageNature, 1996
- Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.The Journal of Experimental Medicine, 1996
- Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity.Journal of Clinical Investigation, 1994